Karuna Therapeutics
IPO News: Filed S-1/A: Karuna Therapeutics Launches 4.375mm Share IPO with $15.00 - $17.00 Marketing Range
Karuna Therapeutics

Karuna Therapeutics

Exchange: NASDAQ

NASDAQ: KRTX

Initial Filing Date: 05/31/19

Launch Date: 06/17/19

Price Range: $15.00 - $17.00

Initial Shares Offered (mm): 4.4

Shares Offered (Pre-Shoe | mm): 4.4

Primary Shares (mm): 4.4

Secondary Shares (mm): 0.0

Amount Offered (@ Midpoint)(mm): $70.0

% Secondary: 0.0%

Shares Outstanding (mm): 21.4

Market Value at Midpoint (mm): $341.9

Offering as % of Market Value: 20.5%

Bookrunner(s): GS | CITI | WF

Co-Manager(s): WED

Major Holder(s): PureTech Health LLC | ARCH Ventures | Directors | The Welcome Trust Limited

Industry: Healthcare-Biomed/Genetics

Description: Karuna Therapeutics is an innovative clinical-stage biopharmaceutical company primarily focused on developing novel therapies to address disabling neuropsychiatric conditions characterized by significant unmet medical need.

Note: Emerging Growth Company

Reference Link: S-1/A